These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 15599148)

  • 1. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
    Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
    Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
    Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control.
    Bellomo R; Farmer M; Bhonagiri S; Porceddu S; Ariens M; M'Pisi D; Ronco C
    Int J Artif Organs; 1999 Mar; 22(3):145-50. PubMed ID: 10357242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
    Bellomo R; McGrath B; Boyce N
    Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.
    Bouman CS; Oudemans-Van Straaten HM; Tijssen JG; Zandstra DF; Kesecioglu J
    Crit Care Med; 2002 Oct; 30(10):2205-11. PubMed ID: 12394945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.
    Leblanc M; Garred LJ; Cardinal J; Pichette V; Nolin L; Ouimet D; Geadah D
    Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
    Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
    Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
    Pea F; Viale P; Lugano M; Pavan F; Scudeller L; Della Rocca G; Furlanut M
    Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of linezolid via continuous venovenous hemodiafiltration.
    Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
    Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of continuous venovenous hemodiafiltration in critically ill patients with acute renal failure.
    Bellomo R; Farmer M; Boyce N
    J Intensive Care Med; 1995; 10(4):187-92. PubMed ID: 10155183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure.
    Swartz RD; Bustami RT; Daley JM; Gillespie BW; Port FK
    Clin Nephrol; 2005 May; 63(5):335-45. PubMed ID: 15909592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury.
    Atan R; Peck L; Prowle J; Licari E; Eastwood GM; Storr M; Goehl H; Bellomo R
    Crit Care Med; 2018 Oct; 46(10):e988-e994. PubMed ID: 30074491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure.
    Fliser D; Kielstein JT
    Curr Opin Crit Care; 2004 Dec; 10(6):483-8. PubMed ID: 15616390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
    Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
    Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.